3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
40
Observational
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Lymphoid
2
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, B-Cell
1
Interventions
Blood Specimen Collection
53
Surveys and Questionnaires
49
Specimen Handling
29
Observation
15
Radiotherapy
14
Magnetic Resonance Spectroscopy
12
Surgical Procedures, Operative
11
Interviews as Topic
11
Data Collection
11
Drug Therapy
9
darolutamide
8
Biopsy
8
palbociclib
7
Watchful Waiting
7
Tomography, X-Ray Computed
7
Standard of Care
7
ribociclib
6
Magnetic Resonance Imaging
6
Bevacizumab
6
trastuzumab deruxtecan
5
Ultrasonography
5
Restraint, Physical
5
Radiofrequency Ablation
5
Patient Reported Outcome Measures
5
Mental Status and Dementia Tests
5
Mastectomy, Segmental
5
Mass Screening
5
Genetic Testing
5
Breath Tests
5
enzalutamide
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Observational
×
acalabrutinib
×
90 days
×
Clear all
NCT05557695
2026-06-02
EPIC
AstraZeneca
Recruiting
350 enrolled
NCT06205498
2026-04-23
ARISE
AstraZeneca
Active not recruiting
151 enrolled